| Name | CDK7-IN-18 |
|---|
| Description | CDK7-IN-18 is a potent inhibitor of CDK7. CDK7-IN-18 is a pyrimidinyl derivative compound. CDK7-IN-18 has the potential for the research of various cancers, especially the cancer with transcriptional dysregulation (extracted from patent CN114249712A, compound 15)[1]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C22H24F3N7OS |
|---|---|
| Molecular Weight | 491.53 |